What is the Ownership and Shareholding Structure of Lumax Pharmaceutical Laboratories?
In 2017, Lumax Pharmaceutical Laboratories had a promoter holding of 51.53% and a public holding of 48.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX